Clinical Trial Update: Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder. [Phase 2]

View source ↗

Summary

Pfizer conducted a Phase 2 dose-finding trial comparing fesoterodine to placebo for efficacy, tolerability and safety in overactive bladder; the study is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Toviaz (fesoterodine fumarate)

Snippet

Sponsor: Pfizer | Conditions: Overactive Bladder | Phase 2 | Status: COMPLETED | Results posted: 2010-09-09